HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

D-tagatose

This article was originally published in The Rose Sheet

Executive Summary

Final rule on d-tagatose permits products containing sugar-based ingredient to bear dental caries health claim, but not "sugar free" statement on labeling, FDA announces in a July 3 Federal Register notice. Rule finalizes an interim final rule released Dec. 2, 2002. Jan. 9 petition by Arla Foods requested the agency include d-tagatose in list of substances that may carry the dental caries claim and to remove the ingredient from the list of "sugars." FDA will permit labeling bearing statement that d-tagatose "does not promote, or may reduce the risk of, tooth decay." Denmark-based Arla Foods said d-tagatose currently is being tested in various consumer products, and branded products carrying the ingredient could launch nationwide this summer...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011335

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel